Correction: Recent Developments and Therapeutic Strategies Against Hepatocellular Carcinoma

Overview

Journal Cancer Res

Specialty Oncology

Date 2019 Nov 28

PMID 31772073

Citations 4

Authors

Mark Yarchoan

Parul Agarwal

Augusto Villanueva

Shuyun Rao

Laura Dawson

Thomas Karasic

Joseph Llovet

Richard Finn

John Groopman

Hashem El-Serag

Satdarshan Monga

Xin Wei Wang

Michael Karin

Robert Schwartz

Kenneth Tanabe

Lewis Roberts

Preethi Gunaratne

Allan Tsung

Kimberly Brown

Theodore Lawrence

Riad Salem

Amit Singal

Amy Kim

Atoosa Rabiee

Linda Resar

Jeffrey Meyer

Yujin Hoshida

Aiwu Ruth He

Kalpana Ghoshal

Patrick Ryan

Elizabeth Jaffee

Chandan Guha

Lopa Mishra

Norman Coleman

Mansoor Ahmed

Affiliations

Soon will be listed here.

Citing Articles

Poly l-Lactic Acid Nanofiber Membrane Effectively Inhibits Liver Cancer Cells Growth and Prevents Postoperative Residual Cancer Recurrence.

Li Y, Ji W, Wang C, Chang L, Zhang Q, Gao J ACS Appl Mater Interfaces. 2024; 17(1):689-700.

PMID: 39681510 PMC: 11783531. DOI: 10.1021/acsami.4c18625.

Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer.

Li Y, Zou H, Zheng Z, Liu Z, Hu H, Wu W Int J Nanomedicine. 2023; 18:2721-2735.

PMID: 37250475 PMC: 10216871. DOI: 10.2147/IJN.S399146.

Emerging Therapies for Hepatocellular Carcinoma (HCC).

Chakraborty E, Sarkar D Cancers (Basel). 2022; 14(11).

PMID: 35681776 PMC: 9179883. DOI: 10.3390/cancers14112798.

Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.

Wu S, He G, Liu S, Cao Y, Geng C, Pan H Int J Med Sci. 2022; 19(4):618-630.

PMID: 35582419 PMC: 9108408. DOI: 10.7150/ijms.69645.

The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.

Li L, Xia S, Shi X, Chen X, Shang D Sci Rep. 2021; 11(1):10728.

PMID: 34021184 PMC: 8139963. DOI: 10.1038/s41598-021-89747-7.